Curis Inc. | Mutual Funds
Mutual Funds that own Curis Inc.
Vanguard Total Stock Market Index Fund
673,049
2.02%
0
0%
07/31/2018
iShares Nasdaq Biotechnology ETF
380,243
1.14%
-4,977
0.01%
09/06/2018
Vanguard Extended Market Index Fund
360,860
1.09%
0
0%
07/31/2018
Candriam Equities L - Biotechnology
160,000
0.48%
0
0.02%
07/31/2018
Fidelity Spartan Extended Market Index Fund
114,957
0.35%
0
0%
07/31/2018
CREF Stock Account
112,018
0.34%
70,027
0%
03/31/2018
Bridgeway Ultra Small Company Market Fund
75,492
0.23%
0
0.03%
12/31/2017
Fidelity Spartan Small Cap Index Fund
53,482
0.16%
1,071
0%
04/30/2018
FCP OP Medical BioHe@lth-Trends
48,289
0.15%
0
0.05%
11/30/2017
Vanguard Institutional Total Stock Market Index Fund
37,775
0.11%
0
0%
07/31/2018
| Address |
4 Maguire Road
Lexington Massachusetts 02421
United States
|
|
Employees
|
- |
| Website |
http://www.curis.com |
| Updated |
07/08/2019 |
| Curis, Inc. is a biotechnology company, which is focused on the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. |
